FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051214926> ?p ?o ?g. }

• W2051214926 endingPage "2178" @default.
• W2051214926 startingPage "2166" @default.
• W2051214926 abstract "Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, regulates multiple cellular responses such as Ca2+ signaling, growth, survival, and differentiation. Because sphingosine kinase (SphK) is the enzyme directly responsible for production of S1P, many factors have been identified that regulate its activity and subsequent S1P levels. Here we synthesized a previously unidentified SphK activator, K6PC-5, and have studied its effects on intracellular Ca2+ signaling in HaCaT cells and epidermal differentiation in murine skin. K6PC-5, a hydrophobic compound chemically named N-(1,3-dihydroxyisopropyl)-2-hexyl-3-oxo-decanamide, activated SphK (obtained from C57BL/6 murine blood and F9-12 cell lysates) in a dose-dependent manner. K6PC-5 induced both intracellular Ca2+ concentration ([Ca2+]i) oscillations in HaCaT cells and Ca2+ mobilization in hairless mouse epidermis. Both dimethylsphingosine (DMS) and dihydroxysphingosine (DHS), SphK inhibitors, and transfection of SphK1-siRNA blocked K6PC-5-induced increases in [Ca2+]i. The K6PC-5-induced [Ca2+]i oscillations were dependent on thapsigargin-sensitive Ca2+ stores and Ca2+ entry, but independent of the classical phospholipase C-mediated pathway. In addition, K6PC-5 enhanced the expression of involucrin and filaggrin, specific differentiation-associated marker proteins in HaCaT cells, whereas transfection of SphK1-siRNA blocked the increase of involucrin. Topical K6PC-5 also enhanced the expression of involucrin, loricrin, filaggrin, and keratin 5 in intact murine epidermis. Finally, topical K6PC-5 inhibited epidermal hyperplasia by exerting antiproliferative effects on keratinocytes in murine epidermis. These results suggest that K6PC-5 acts to regulate both differentiation and proliferation of keratinocytes via [Ca2+]i responses through S1P production. Thus, regulation of S1P levels may represent a novel approach for treatment of skin disorders characterized by abnormal differentiation and proliferation, such as atopic dermatitis and psoriasis. Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, regulates multiple cellular responses such as Ca2+ signaling, growth, survival, and differentiation. Because sphingosine kinase (SphK) is the enzyme directly responsible for production of S1P, many factors have been identified that regulate its activity and subsequent S1P levels. Here we synthesized a previously unidentified SphK activator, K6PC-5, and have studied its effects on intracellular Ca2+ signaling in HaCaT cells and epidermal differentiation in murine skin. K6PC-5, a hydrophobic compound chemically named N-(1,3-dihydroxyisopropyl)-2-hexyl-3-oxo-decanamide, activated SphK (obtained from C57BL/6 murine blood and F9-12 cell lysates) in a dose-dependent manner. K6PC-5 induced both intracellular Ca2+ concentration ([Ca2+]i) oscillations in HaCaT cells and Ca2+ mobilization in hairless mouse epidermis. Both dimethylsphingosine (DMS) and dihydroxysphingosine (DHS), SphK inhibitors, and transfection of SphK1-siRNA blocked K6PC-5-induced increases in [Ca2+]i. The K6PC-5-induced [Ca2+]i oscillations were dependent on thapsigargin-sensitive Ca2+ stores and Ca2+ entry, but independent of the classical phospholipase C-mediated pathway. In addition, K6PC-5 enhanced the expression of involucrin and filaggrin, specific differentiation-associated marker proteins in HaCaT cells, whereas transfection of SphK1-siRNA blocked the increase of involucrin. Topical K6PC-5 also enhanced the expression of involucrin, loricrin, filaggrin, and keratin 5 in intact murine epidermis. Finally, topical K6PC-5 inhibited epidermal hyperplasia by exerting antiproliferative effects on keratinocytes in murine epidermis. These results suggest that K6PC-5 acts to regulate both differentiation and proliferation of keratinocytes via [Ca2+]i responses through S1P production. Thus, regulation of S1P levels may represent a novel approach for treatment of skin disorders characterized by abnormal differentiation and proliferation, such as atopic dermatitis and psoriasis. intracellular Ca2+ concentration fetal bovine serum proliferating-cell nuclear antigen physiological salt solution sphingosine-1-phosphate stratum corneum small interfering RNA sphingosine kinase thapsigargin" @default.
• W2051214926 created "2016-06-24" @default.
• W2051214926 creator A5007271184 @default.
• W2051214926 creator A5025828391 @default.
• W2051214926 creator A5035365873 @default.
• W2051214926 creator A5040027626 @default.
• W2051214926 creator A5053538472 @default.
• W2051214926 creator A5074764833 @default.
• W2051214926 creator A5075084878 @default.
• W2051214926 creator A5087522114 @default.
• W2051214926 date "2008-09-01" @default.
• W2051214926 modified "2023-10-16" @default.
• W2051214926 title "K6PC-5, a Direct Activator of Sphingosine Kinase 1, Promotes Epidermal Differentiation Through Intracellular Ca2+ Signaling" @default.
• W2051214926 cites W1501693497 @default.
• W2051214926 cites W1511945780 @default.
• W2051214926 cites W1670077883 @default.
• W2051214926 cites W1837897734 @default.
• W2051214926 cites W1929157658 @default.
• W2051214926 cites W1967939988 @default.
• W2051214926 cites W1968816568 @default.
• W2051214926 cites W1978070495 @default.
• W2051214926 cites W1978421075 @default.
• W2051214926 cites W1981852211 @default.
• W2051214926 cites W1985110367 @default.
• W2051214926 cites W1985375860 @default.
• W2051214926 cites W1989975786 @default.
• W2051214926 cites W1993449698 @default.
• W2051214926 cites W1994276274 @default.
• W2051214926 cites W1995391501 @default.
• W2051214926 cites W1996192399 @default.
• W2051214926 cites W2013264233 @default.
• W2051214926 cites W2015051992 @default.
• W2051214926 cites W2021722796 @default.
• W2051214926 cites W2022770236 @default.
• W2051214926 cites W2023384909 @default.
• W2051214926 cites W2023811060 @default.
• W2051214926 cites W2026341287 @default.
• W2051214926 cites W2027429767 @default.
• W2051214926 cites W2028378028 @default.
• W2051214926 cites W2028436452 @default.
• W2051214926 cites W2034381586 @default.
• W2051214926 cites W2037231703 @default.
• W2051214926 cites W2038085058 @default.
• W2051214926 cites W2038805435 @default.
• W2051214926 cites W2045472186 @default.
• W2051214926 cites W2047231993 @default.
• W2051214926 cites W2055945784 @default.
• W2051214926 cites W2062899886 @default.
• W2051214926 cites W2069771076 @default.
• W2051214926 cites W2073829786 @default.
• W2051214926 cites W2075716048 @default.
• W2051214926 cites W2076301201 @default.
• W2051214926 cites W2077215651 @default.
• W2051214926 cites W2077796802 @default.
• W2051214926 cites W2081968019 @default.
• W2051214926 cites W2084654786 @default.
• W2051214926 cites W2090542818 @default.
• W2051214926 cites W2091551188 @default.
• W2051214926 cites W2105218146 @default.
• W2051214926 cites W2108825594 @default.
• W2051214926 cites W2124369651 @default.
• W2051214926 cites W2141921458 @default.
• W2051214926 cites W2145800045 @default.
• W2051214926 cites W2146307680 @default.
• W2051214926 cites W2147336880 @default.
• W2051214926 cites W2153904682 @default.
• W2051214926 cites W4242437791 @default.
• W2051214926 cites W4365787918 @default.
• W2051214926 doi "https://doi.org/10.1038/jid.2008.66" @default.
• W2051214926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18385762" @default.
• W2051214926 hasPublicationYear "2008" @default.
• W2051214926 type Work @default.
• W2051214926 sameAs 2051214926 @default.
• W2051214926 citedByCount "41" @default.
• W2051214926 countsByYear W20512149262012 @default.
• W2051214926 countsByYear W20512149262013 @default.
• W2051214926 countsByYear W20512149262014 @default.
• W2051214926 countsByYear W20512149262015 @default.
• W2051214926 countsByYear W20512149262016 @default.
• W2051214926 countsByYear W20512149262017 @default.
• W2051214926 countsByYear W20512149262020 @default.
• W2051214926 countsByYear W20512149262021 @default.
• W2051214926 countsByYear W20512149262022 @default.
• W2051214926 countsByYear W20512149262023 @default.
• W2051214926 crossrefType "journal-article" @default.
• W2051214926 hasAuthorship W2051214926A5007271184 @default.
• W2051214926 hasAuthorship W2051214926A5025828391 @default.
• W2051214926 hasAuthorship W2051214926A5035365873 @default.
• W2051214926 hasAuthorship W2051214926A5040027626 @default.
• W2051214926 hasAuthorship W2051214926A5053538472 @default.
• W2051214926 hasAuthorship W2051214926A5074764833 @default.
• W2051214926 hasAuthorship W2051214926A5075084878 @default.
• W2051214926 hasAuthorship W2051214926A5087522114 @default.
• W2051214926 hasBestOaLocation W20512149261 @default.
• W2051214926 hasConcept C118995209 @default.
• W2051214926 hasConcept C153911025 @default.
• W2051214926 hasConcept C170493617 @default.
• W2051214926 hasConcept C190283241 @default.

• next